biotech · Cholangiocarcinoma · Irritable Bowel Syndrome With Diarrhea · RDHL
RedHill Biopharma
RedHill Biopharma trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US HQ
2009 Founded
43 Employees
Public company Type
RDHL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US
- Founded
- 2009
- Employees
- 43
- Programs
- 14
- Drugs
- 10
- Patents
- 40
RedHill Biopharma clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to RedHill Biopharma programs — each row shows trial ID, program name, phase, status, and indication.
RedHill Biopharma trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for RedHill Biopharma.
-
RHB-104-04 — Phase 3
Clinical update -
Rifamycin SV-MMX — Phase 2
Clinical update -
Part A: Upamostat 200 mg — Phase 3
Clinical update -
Opaganib — Phase 3
Clinical update -
Upamostat — Phase 2
Clinical update -
RHB-104 — Phase 2
Clinical update -
RHB-102 — Phase 3
Clinical update -
RHB-104 — Phase 3
Clinical update